✦ LIBER ✦

Intratumor administration of beta-interferon in recurrent malignant gliomas. A phase I clinical and laboratory study

✍ Scribed by Michael R. Fetell; Edgar M. Housepian; Martin W. Oster; Debra N. Cote; Michael B. Sisti; Stephen G. Marcus; Paul B. Fisher

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 595 KB
Volume: 65
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900101)65:1<78::aid-cncr2820650117>3.0.co;2-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I clinical trial of interferon-b

A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy

✍ Toshihiko Wakabayashi; Atsushi Natsume; Yoshio Hashizume; Masazumi Fujii; Masaak 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 731 KB

## Abstract ## Background High‐grade gliomas are highly lethal neoplasms representing approximately 20% of all intracranial tumors. Cationic liposome‐mediated interferon‐beta (__IFN‐__β) gene transfer has been found to induce regression of experimental glioma. We have previously performed a pilot

Phase I study of recombinant leukocyte a

Phase I study of recombinant leukocyte a interferon (IFN-α2A, roferon-A) with doxorubicin in advanced malignant disease

✍ Edward T. Creagan; Stephen Frytak; Harry J. Long; Larry K. Kvols 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB 👁 1 views

A phase I study of recombinant human int

A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma

✍ A. Mittelman; M. Huberman; C. Puccio; B. Fallon; J. Tessitore; S. Savona; R. Eyr 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 662 KB

Preclinical data suggest synergy of interleukin-2 (IL-2) combined with alphainterferon (IFN). In addition, toxicities of IL-2 may be decreased by intermittent continuous infusion. The purpose of this trial was to determine the maximum tolerated dose (MTD) of recombinant IL-2 combined with alpha-IFN

Hyperthermia for the treatment of patien

Hyperthermia for the treatment of patients with malignant germ cell tumors : A Phase I/II study in ten children and adolescents with recurrent or refractory tumors

✍ Rüdiger Wessalowski; Heidi Kruck; Hildegard Pape; Thomas Kahn; Reinhart Willers; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 3 views

waves in combination with platinum-based chemotherapy in ten children and 4 Institute of Statistics, Heinrich-Heine Univeradolescents with recurrent or refractory GCTs. sity, Du ¨sseldorf, Germany. ## RESULTS. Seven of ten patients with recurrent or refractory GCTs had objective responses. Of the

Phase I clinical study of a static magne

Phase I clinical study of a static magnetic field combined with anti-neoplastic chemotherapy in the treatment of human malignancy: Initial safety and toxicity data

✍ Joseph R. Salvatore; Joanne Harrington; Thomas Kummet 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views